MLN51

MLN51, also known as MYSM1 or MYSM1-AS1, is a long non-coding RNA (lncRNA) that plays a role in epigenetic regulation. It is primarily involved in the regulation of gene expression through interactions with chromatin-modifying complexes. MLN51 has been found to interact with the MYSM1 protein, which is a component of the histone demethylase complex. This interaction suggests that MLN51 may contribute to the recruitment or activity of MYSM1, thereby influencing the epigenetic landscape of the cell.

Research has indicated that MLN51 is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis. Its dysregulation has been implicated in certain diseases, particularly in cancer. Studies have shown altered expression levels of MLN51 in various types of cancer, and it has been proposed to function as either an oncogene or a tumor suppressor depending on the specific cellular context and cancer type. The precise mechanisms by which MLN51 exerts its effects are still under investigation, but its role in modulating gene expression through epigenetic pathways is a key area of focus. Further research is needed to fully elucidate the functions of MLN51 and its potential as a therapeutic target.